3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Parasomnias
2
Lung Neoplasms
2
Weight Loss
1
Uveal Melanoma
1
Tuberous Sclerosis
1
Squamous Cell Carcinoma of Head and Neck
1
Smith-Magenis Syndrome
1
Sleep Wake Disorders
1
Neoplasms
1
Gastrointestinal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Cachexia
1
Breast Cancer - Female
1
Barrett Esophagus
1
Autism Spectrum Disorder
1
Anorexia
1
Angelman Syndrome
1
Interventions
Melphalan
3
tebentafusp
1
sargramostim
1
fotemustine
1
aflibercept
1
Ranibizumab
1
Nivolumab
1
Neoadjuvant Therapy
1
Melatonin
1
MART-1 Antigen
1
Ipilimumab
1
Eye Enucleation
1
Dacarbazine
1
Colony-Stimulating Factors
1
Chemotherapy, Cancer, Regional Perfusion
1
Brachytherapy
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Uveal Melanoma
×
Melatonin
×
Clear all
NCT05502900
2025-05-15
AMUM
St. Erik Eye Hospital
Phase 3
Recruiting
100 enrolled